GWAS 2024-01-27

Park J, Park IS et al.

Therap Adv Gastroenterol

Notably, 5-aminosalicylates (5-ASA) are vital in treating inflammatory bowel diseases (IBD). The adv...

Response to 5-aminosalicylate in inflammatory bowel disease (mild adverse events)

311

Participants

N/A

Studies

Title

Author

Journal

Disease/Trait

Date

Actions

Park J, Park IS et al.

Therap Adv Gastroenterol

Response to 5-aminosalicylate in inflammatory bowel disease (mild adverse events)

2024-01-27